JAK2, Janus kinase 2, 3717

N. diseases: 644; N. variants: 54
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Precursor B-cell lymphoblastic leukemia
0.100 GeneticVariation disease BEFREE In this study, we examined the diagnostic (n = 77) and relapsed (n = 31) pediatric B-cell acute lymphoblastic leukemia (B-ALL) samples for the most common leukemia-associated gene variations CRLF2, JAK2, PAX5 and IL7R using deep sequencing and copy number alterations (CNAs) (CDKN2A/2B, PAX5, RB1, BTG1, ETV6, CSF2RA, IL3RA and CRLF2) by multiplex ligation proximity assay (MLPA), and evaluated for the clonal changes through relapse. 31228652 2019
Precursor B-cell lymphoblastic leukemia
0.100 GeneticVariation disease BEFREE Combined indirect targeting of c-Myc using the BET bromodomain inhibitor JQ1 and direct targeting of JAK2 with ruxolitinib potently killed JAK2 mutant B-ALLs. 29907650 2018
Precursor B-cell lymphoblastic leukemia
0.100 GeneticVariation disease BEFREE We report a novel somatic mutation in the kinase domain of JAK2 (R938Q) in a high-risk pediatric case of B-cell acute lymphoblastic leukemia (ALL). 29025600 2017
Precursor B-cell lymphoblastic leukemia
0.100 GeneticVariation disease BEFREE MFC allows a rapid, inexpensive, and reliable detection of B-ALL with CRLF2 rearrangement that would further facilitate testing for JAK2 mutations for targetable therapy. 28340183 2017
Precursor B-cell lymphoblastic leukemia
0.100 Biomarker disease BEFREE In this issue of Cancer Cell, two articles by Wu and colleagues and Meyer and colleagues characterize a type II JAK2 inhibitor that is effective in preclinical models of JAK2-dependent myeloproliferative neoplasms and B cell acute lymphoblastic leukemia. 26175407 2015
Precursor B-cell lymphoblastic leukemia
0.100 Biomarker disease BEFREE Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia. 26175414 2015
Precursor B-cell lymphoblastic leukemia
0.100 GeneticVariation disease BEFREE The results herein may provide clues to understanding the mechanism of JAK2 R683G(S) mutation-associated B-ALL. 23452118 2013
Precursor B-cell lymphoblastic leukemia
0.100 GeneticVariation disease BEFREE This study provides clues in understanding the mechanism of JAK2 R683S (G) mutations caused B-ALL. 23748007 2013
Precursor B-cell lymphoblastic leukemia
0.100 Biomarker disease BEFREE In addition, the HSP90 inhibitor AUY922 prolonged survival of mice xenografted with primary human CRLF2-rearranged B-ALL further than an enzymatic JAK2 inhibitor. 22271575 2012
Precursor B-cell lymphoblastic leukemia
0.100 GeneticVariation disease BEFREE CRLF2 rearrangements, JAK1/2 point mutations, and JAK2 fusion genes have been identified in Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia (ALL), a recently described subtype of pediatric high-risk B-precursor ALL (B-ALL) which exhibits a gene expression profile similar to Ph-positive ALL and has a poor prognosis. 22955920 2012
Precursor B-cell lymphoblastic leukemia
0.100 GeneticVariation disease BEFREE Novel JAK2 rearrangement resulting from a t(9;22)(p24;q11.2) in B-acute lymphoblastic leukemia. 20594592 2010
Precursor B-cell lymphoblastic leukemia
0.100 GeneticVariation disease BEFREE In fact, all 22 B-ALLs with mutant JAK2 that we analyzed overexpress CRLF2, distinguishing CRLF2 as the key scaffold for mutant JAK2 signaling in B-ALL. 20018760 2010
Precursor B-cell lymphoblastic leukemia
0.100 GeneticVariation disease BEFREE In this report, we identify SSBP2 as a new JAK2 fusion partner in a patient with pre-B cell acute lymphocytic leukemia. 18618714 2008
Precursor B-cell lymphoblastic leukemia
0.100 GeneticVariation disease BEFREE Furthermore, we demonstrate a novel translocation in this tumor, the t(5;9)(q31;p24), that possibly led to fusion of the interleukin-3 (IL3) (5q31) and JAK2 (9p24) genes and may explain the concomitant appearance of eosinophilia and ALL. 12708906 2003
Precursor B-cell lymphoblastic leukemia
0.100 GeneticVariation disease BEFREE We show here that a t(9;12)(p24;p13) in a case of early pre-B acute lymphoid leukemia and a t(9;15;12)(p24;q15;p13) in atypical chronic myelogenous leukemia in transformation involve the ETV6 gene at 12p13 and the JAK2 gene at 9p24. 9326218 1997